Teachers Advisors LLC cut its stake in Mednax, Inc (NYSE:MD) by 13.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 106,582 shares of the company’s stock after selling 16,509 shares during the period. Teachers Advisors LLC owned about 0.11% of Mednax worth $6,434,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of MD. Eagle Boston Investment Management Inc. grew its holdings in Mednax by 12.9% during the 2nd quarter. Eagle Boston Investment Management Inc. now owns 191,636 shares of the company’s stock worth $11,569,000 after acquiring an additional 21,895 shares in the last quarter. Swiss National Bank grew its holdings in Mednax by 3.0% during the 2nd quarter. Swiss National Bank now owns 341,700 shares of the company’s stock worth $20,628,000 after acquiring an additional 9,900 shares in the last quarter. South Dakota Investment Council grew its holdings in Mednax by 24.5% during the 2nd quarter. South Dakota Investment Council now owns 50,800 shares of the company’s stock worth $3,067,000 after acquiring an additional 10,000 shares in the last quarter. Mn Services Vermogensbeheer B.V. grew its holdings in Mednax by 527.2% during the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 15,228 shares of the company’s stock worth $919,000 after acquiring an additional 12,800 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Mednax by 55.2% during the 1st quarter. JPMorgan Chase & Co. now owns 79,610 shares of the company’s stock worth $5,524,000 after acquiring an additional 28,301 shares in the last quarter.

Shares of Mednax, Inc (NYSE:MD) opened at 43.62 on Friday. The stock has a 50 day moving average of $43.10 and a 200-day moving average of $54.06. Mednax, Inc has a 12-month low of $40.78 and a 12-month high of $72.13. The company has a market capitalization of $4.02 billion, a PE ratio of 13.89 and a beta of 0.37.

Mednax (NYSE:MD) last announced its quarterly earnings data on Friday, July 28th. The company reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.04. Mednax had a return on equity of 11.89% and a net margin of 8.78%. The business had revenue of $843.00 million during the quarter, compared to the consensus estimate of $849.49 million. During the same period in the previous year, the company posted $1.03 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Analysts predict that Mednax, Inc will post $3.31 earnings per share for the current fiscal year.

In other news, insider John C. Pepia sold 3,000 shares of the business’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $42.85, for a total transaction of $128,550.00. Following the completion of the transaction, the insider now directly owns 35,569 shares of the company’s stock, valued at $1,524,131.65. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 2.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Mednax, Inc (MD) Shares Sold by Teachers Advisors LLC” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/mednax-inc-md-shares-sold-by-teachers-advisors-llc/1616931.html.

Several research analysts have issued reports on MD shares. BidaskClub upgraded shares of Mednax from a “strong sell” rating to a “sell” rating in a report on Tuesday, June 13th. Stephens upgraded shares of Mednax from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $55.00 to $68.00 in a report on Thursday, June 22nd. Jefferies Group LLC reiterated a “hold” rating and set a $53.00 target price (up from $50.00) on shares of Mednax in a report on Thursday, July 6th. Mizuho reiterated a “neutral” rating and set a $48.00 target price (down from $62.00) on shares of Mednax in a report on Tuesday, August 1st. Finally, Robert W. Baird reiterated a “hold” rating and set a $47.00 target price on shares of Mednax in a report on Sunday, September 3rd. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. Mednax presently has a consensus rating of “Hold” and a consensus price target of $56.63.

About Mednax

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

Institutional Ownership by Quarter for Mednax (NYSE:MD)

Receive News & Ratings for Mednax Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mednax Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.